Cerebrolysin
Disorder of Consciousness
Konkuk University Medical CentermixturePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Disorder of Consciousness cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Amantadine Weill Medical College of Cornell University | Early Phase 1 | C |
LEVODOPA Weill Medical College of Cornell University | Early Phase 1 | C |
Same molecule, other indications
Cerebrolysin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →